Schedule 13G ownership disclosure
Evofem Biosciences Operations, Inc.
Security class unavailable · CUSIP: 30048L104
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 7,631,470
- Percent of class
- 5.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000895421-21-000381
- Form type
- SC 13G
- Filer
- Evofem Biosciences, Inc.
- CIK
- CIK 1618835
- Filed
- Jun 04, 2021
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership